Several pro-angiogenic molecules, such as the vascular endothelial growth factor (VEGF), have been linked to a range of immunosuppressive effects at successive steps in the cancer immunity cycle, such as antigen presentation, T-cell priming, T-cell trafficking, and T-cell tumor infiltration (35). The gene discussed is VEGFA; the disease is neoplasm.